Rare Papillary Thyroid Carcinomas

  • José M. Cameselle-Teijeiro
  • Catarina Eloy
  • Isabel Amendoeira
  • Paula Soares
  • Javier Caneiro-Gómez
  • Miguel Melo
  • Manuel Sobrinho-Simões
Chapter

Abstract

Papillary thyroid carcinoma (PTC) is a malignant epithelial tumour showing evidence of follicular cell differentiation and a set of distinctive nuclear features. Following the criteria of the last WHO classification, either papillae or invasion is required for a diagnosis of PTC [1]. Although the diagnosis of PTC is not usually problematic, numerous variants of PTC have been recognized, sometimes raising diagnostic difficulties. In the follicular-patterned tumours with PTC nuclear features, the diagnosis is based primarily on the identification of invasion signs and will not be addressed in this book [1, 2]. It is particularly important to recognize those variants of PTC that are associated with clinical aggressiveness, as is the case with tall cell variant, columnar cell variant, the recently described hobnail (micropapillary) variant of PTC and PTC displaying diffuse nuclear immunoreactivity for P53. Since the hobnail (micropapillary) variant of PTC is the rarest form of the aforementioned three morphologic variants and its diagnosis is more difficult, it will be specially addressed in this chapter, together with other (very) unusual forms of PTC.

References

  1. 1.
    Lloyd RV, Osamura RY, Klöppel G, Rosai J, editors. World Health Organization classification of tumours. pathology and genetics of tumours of endocrine organs. Lyon: IARC Press; 2017.Google Scholar
  2. 2.
    Rosai J, DeLellis RA, Carcangiu ML, Frable WJ, Tallini G. Tumors of the thyroid and parathyroid glands, AFIP Atlas of Tumor Pathology. Series 4. Fascicle 21. Silver Spring, MD: American Registry of Pathology; 2014.Google Scholar
  3. 3.
    Asioli S, Erickson LA, Righi A, Lloyd RV. Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior. Hum Pathol. 2013;44:320–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Lee YS, Kim Y, Jeon S, Bae JS, Jung SL, Jung CK. Cytologic, clinicopathologic, and molecular features of papillary thyroid carcinoma with prominent hobnail features: 10 case reports and systematic literature review. Int J Clin Exp Pathol. 2015;8:7988–97.PubMedCentralPubMedGoogle Scholar
  5. 5.
    Amacher AM, Goyal B, Lewis JS Jr, El-Mofty SK, Chernock RD. Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation. Am J Surg Pathol. 2015;39:260–5.CrossRefPubMedGoogle Scholar
  6. 6.
    Motosugi U, Murata S, Nagata K, Yasuda M, Shimizu M. Thyroid papillary carcinoma with micropapillary and hobnail growth pattern: a histological variant with intermediate malignancy? Thyroid. 2009;19:535–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Lubitz CC, Economopoulos KP, Pawlak AC, Lynch K, Dias-Santagata D, Faquin WC, Sadow PM. Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile. Thyroid. 2014;24:958–65.CrossRefPubMedCentralPubMedGoogle Scholar
  8. 8.
    Cameselle-Teijeiro JM, Rodríguez-Pérez I, Celestino R, Eloy C, Piso-Neira M, Abdulkader-Nallib I, Soares P, Sobrinho-Simões M. Hobnail variant of papillary thyroid carcinoma: clinicopathologic and molecular evidence of progression to undifferentiated carcinoma in 2 cases. Am J Surg Pathol. 2017;41(6):854–60.CrossRefPubMedGoogle Scholar
  9. 9.
    Lino-Silva LS, Domínguez-Malagón HR, Caro-Sánchez CH, Salcedo-Hernández RA. Thyroid gland papillary carcinomas with micropapillary pattern, a recently recognized poor prognostic finding: clinicopathologic and survival analysis of 7 cases. Hum Pathol. 2012;43:1596–600.CrossRefPubMedGoogle Scholar
  10. 10.
    Asioli S, Maletta F, Pagni F, Pacchioni D, Vanzati A, Mariani S, Palestini N, Lloyd RV, Sapino A. Cytomorphologic and molecular features of hobnail variant of papillary thyroid carcinoma: case series and literature review. Diagn Cytopathol. 2014;42:78–84.CrossRefPubMedGoogle Scholar
  11. 11.
    Bellevicine C, Cozzolino I, Malapelle U, Zeppa P, Troncone G. Cytological and molecular features of papillary thyroid carcinoma with prominent hobnail features: a case report. Acta Cytol. 2012;56:560–4.CrossRefPubMedGoogle Scholar
  12. 12.
    Yang GC, Fried K, Scognamiglio T. Cytological features of clear cell thyroid tumors, including a papillary thyroid carcinoma with prominent hobnail features. Diagn Cytopathol. 2013;41:757–61.CrossRefPubMedGoogle Scholar
  13. 13.
    Asioli S, Erickson LA, Sebo TJ, Zhang J, Jin L, Thompson GB, Lloyd RV. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol. 2010;34:44–52.CrossRefPubMedGoogle Scholar
  14. 14.
    Albores-Saavedra J. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of 8 cases. Am J Surg Pathol. 2010;34:913.CrossRefPubMedGoogle Scholar
  15. 15.
    Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, Lloyd RV, LiVolsi VA, Papotti M, Sobrinho-Simoes M, Bussolati G, Rosai J. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol. 2007;31:1256–64.CrossRefPubMedGoogle Scholar
  16. 16.
    Tavares C, Melo M, Cameselle-Teijeiro JM, Soares P, Sobrinho-Simões M. ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome. Eur J Endocrinol. 2016;174:R117–26.CrossRefPubMedGoogle Scholar
  17. 17.
    Woenckhaus C, Cameselle-Teijeiro J, Ruiz-Ponte C, Abdulkader I, Reyes-Santías R, Sobrinho-Simões M. Spindle cell variant of papillary thyroid carcinoma. Histopathology. 2004;45:424–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Rebecchini C, Nobile A, Piana S, Sarro R, Bisig B, Gerasimos SP, Saglietti C, Matter M, Marino L, Bongiovanni M. Papillary thyroid carcinoma with nodular fasciitis-like stroma and β-catenin mutations should be renamed papillary thyroid carcinoma with desmoid-type fibromatosis. Mod Pathol. 2017;30(2):236–45.CrossRefPubMedGoogle Scholar
  19. 19.
    Vigliar E, Bellevicine C, Cozzolino I, Zeppa P. Histological and fine needle aspiration cytological features of Hashimoto thyroiditis-associated 'angiomatoid' papillary thyroid carcinoma. Cytopathology. 2012;23(6):415–7.CrossRefPubMedGoogle Scholar
  20. 20.
    Chen JH, Faquin WC, Lloyd RV, Nosé V. Clinicopathological and molecular characterization of nine cases of columnar cell variant of papillary thyroid carcinoma. Mod Pathol. 2011;24(5):739–49.CrossRefPubMedGoogle Scholar
  21. 21.
    Cameselle-Teijeiro J, Alberte-Lista L, Peteiro-González D, Abdulkader-Nallib I, Reyes-Santías R, Soares P, Sobrinho-Simões M. CDX2 expression in some variants of papillary thyroid carcinoma. Am J Clin Pathol. 2012;138:907–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Cameselle-Teijeiro J, Menasce LP, Yap BK, Colaco RJ, Castro P, Celestino R, Ruíz-Ponte C, Soares P, Sobrinho-Simões M. Cribriform-morular variant of papillary thyroid carcinoma: molecular characterization of a case with neuroendocrine differentiation and aggressive behavior. Am J Clin Pathol. 2009;131(1):134–42.CrossRefPubMedGoogle Scholar
  23. 23.
    Nakazawa T, Celestino R, Machado JC, Cameselle-Teijeiro JM, Vinagre J, Eloy C, Benserai F, Lameche S, Soares P, Sobrinho-Simões M. Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features. Int J Surg Pathol. 2013;21(4):379–89.CrossRefPubMedGoogle Scholar
  24. 24.
    Yamaguchi E, Makino Y, Sato T, Uchida M, Harada Y, Maruyama R. CA19-9-producing lung metastasis after surgery for papillary thyroid carcinoma: report of a case. Surg Today. 2014;44:2157–61.CrossRefPubMedCentralPubMedGoogle Scholar
  25. 25.
    Ogawa M, Hori H, Hirayama M, Kobayashi M, Shiraishi T, Watanabe Y, Komada Y. Anaplastic transformation from papillary thyroid carcinoma with increased serum CA19-9. Pediatr Blood Cancer. 2005;45:64–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Nikiforov YE, Nikiforova MN, Gnepp DR, Fagin JA. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident. Oncogene. 1996;13(4):687–93.PubMedGoogle Scholar
  27. 27.
    Nikiforova MN, Wald AI, Roy S, Durso MB, Nikiforov YE. Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer. J Clin Endocrinol Metab. 2013;98(11):E1852–60.CrossRefPubMedCentralPubMedGoogle Scholar
  28. 28.
    Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159:676–90. 49CrossRefGoogle Scholar
  29. 29.
    Rüter A, Dreifus J, Jones M, Nishiyama R, Lennquist S. Overexpression of p53 in tall cell variants of papillary thyroid carcinoma. Surgery. 1996;120(6):1046–50.CrossRefPubMedGoogle Scholar
  30. 30.
    Putti TC, Bhuiya TA. Mixed columnar cell and tall cell variant of papillary carcinoma of thyroid: a case report and review of the literature. Pathology. 2000;32(4):286–9.CrossRefPubMedGoogle Scholar
  31. 31.
    Kleer CG, Giordano TJ, Merino MJ. Squamous cell carcinoma of the thyroid: an aggressive tumor associated with tall cell variant of papillary thyroid carcinoma. Mod Pathol. 2000;13(7):742–6.CrossRefPubMedGoogle Scholar
  32. 32.
    Shah AA, La Fortune K, Miller C, Mills SE, Baloch Z, LiVolsi V, Dacic S, Mahaffey AL, Nikiforova M, Nikiforov YE, Seethala RR. Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia: a clinicopathologic and molecular analysis of a distinct entity. Mod Pathol. 2017;30(3):329–39.CrossRefPubMedGoogle Scholar
  33. 33.
    Yu J, Nikiforova M, Hodak S, et al. Tumor-to-tumor metastases to follicular variant of papillary thyroid carcinoma: histologic, immunohistochemical, and molecular studies of two unusual cases. Endocr Pathol. 2009;20:235–42.CrossRefPubMedGoogle Scholar
  34. 34.
    Eloy C, Vinagre J, Cameselle-Teijeiro J, Paiva ME, Soares P, Sobrinho-Simões M. Tumor-in-tumor of the thyroid with basaloid differentiation: a lesion with a solid cell nest neoplastic component? Int J Surg Pathol. 2011;19:276–80.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • José M. Cameselle-Teijeiro
    • 1
    • 2
  • Catarina Eloy
    • 3
    • 4
    • 5
  • Isabel Amendoeira
    • 3
    • 6
  • Paula Soares
    • 3
    • 4
    • 5
  • Javier Caneiro-Gómez
    • 7
  • Miguel Melo
    • 3
    • 5
    • 8
    • 9
  • Manuel Sobrinho-Simões
    • 3
    • 4
    • 6
    • 5
  1. 1.Department of PathologyClinical University Hospital, Galician Healthcare Service (SERGAS), Health Research Institute of Santiago de Compostela (IDIS)Santiago de CompostelaSpain
  2. 2.Medical FacultyUniversity of Santiago de CompostelaSantiago de CompostelaSpain
  3. 3.Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP)PortoPortugal
  4. 4.Department of Pathology, Medical FacultyUniversity of PortoPortoPortugal
  5. 5.i3S - Instituto de Investigação e Inovação em SaúdePortoPortugal
  6. 6.Department of PathologyHospital S. JoãoPortoPortugal
  7. 7.Department of PathologyHospital Lucus Augusti, Galician Healthcare Service (SERGAS)LugoSpain
  8. 8.Department of Endocrinology, Diabetes and MetabolismCentro Hospitalar e Universitário de CoimbraCoimbraPortugal
  9. 9.Unit of Endocrinology, Faculty of MedicineUniversity of CoimbraCoimbraPortugal

Personalised recommendations